Literature DB >> 20354863

Epithelial tumors of the lacrimal gland in the Chinese: a clinicopathologic study of 298 patients.

Jie Zeng1, Ji-tong Shi, Bin Li, Xian-li Sun, Yu-zhi An, Liao-qing Li, Fei Gao, Jian-ping Xu, Jost B Jonas.   

Abstract

OBJECTIVE: To examine the clinicopathologic characteristics and clinical features of epithelial tumors of lacrimal gland in China.
METHODS: The retrospective case series study included all 298 patients of epithelial lacrimal gland tumors which had been collected in the ophthalmic pathologic laboratory of the Tongren Hospital Beijing in the study period from 1961 to 2005.
RESULTS: Pleomorphic adenomas were the most common tumors (n = 213 (72%)), followed by adenoid cystic carcinoma (n = 58 (20%)), pleomorphic adenocarcinoma (n = 13 (4%)), primary adenocarcinoma (n = 8 (3%)) and other tumors (n = 6 (2%)). The most frequent symptoms and clinical signs were restrictions of the lid or eye motility (121 patients; 41%), any other kind of lid involvement (71 patients; 24%), swelling (57 patients; 19%), pain (57 patients; 8%), and decrease in vision (15 patients; 5%). A restriction of the eye motility was noted for 61 patients (21%), due to an involvement of the extraocular muscles with the tumor and due to a tumor-induced displacement of the globe. Apart from the duration of symptoms, the tumor types did not vary significantly in age, gender, and laterality.
CONCLUSIONS: Based on the archives of the Beijing Tongren ophthalmo-pathological laboratory, the most common epithelial tumors of the lacrimal gland in mainland China were pleomorphic adenomas, followed by adenoid cystic carcinoma. The spectrum and clinical signs of epithelial lacrimal gland tumors did not differ markedly between Chinese patients and Caucasian patients.

Entities:  

Mesh:

Year:  2010        PMID: 20354863     DOI: 10.1007/s00417-010-1349-2

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  12 in total

Review 1.  Review: primary epithelial malignancies of the lacrimal gland: the 2003 Ramon L. Font lecture.

Authors:  Jerry A Shields; Carol L Shields; John A Epstein; Richard Scartozzi; Ralph C Eagle
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2004-01       Impact factor: 1.746

2.  [A follow-up survey of results of lacrimal gland surgery of pleomorphic adenoma].

Authors:  D Tang; H Zhao; G Song
Journal:  Zhonghua Yan Ke Za Zhi       Date:  1997-09

3.  Basal cell adenocarcinoma of the lacrimal gland.

Authors:  M Khalil; B Arthurs
Journal:  Ophthalmology       Date:  2000-01       Impact factor: 12.079

Review 4.  Tumors arising in the palpebral lobe of the lacrimal gland.

Authors:  S Vangveeravong; S E Katz; J Rootman; V White
Journal:  Ophthalmology       Date:  1996-10       Impact factor: 12.079

Review 5.  Orbit and adnexal neoplasia.

Authors:  M Krzystolik; M A Warner
Journal:  Curr Opin Ophthalmol       Date:  1995-10       Impact factor: 3.761

6.  [Photographic diagnosis for common intraorbital tumors].

Authors:  J Shi; G Song; L Xiao
Journal:  Zhonghua Yan Ke Za Zhi       Date:  1997-03

7.  Epithelial lacrimal gland tumors: pathologic classification and current understanding.

Authors:  Ezekiel Weis; Jack Rootman; Thomas J Joly; Kenneth W Berean; Hind M Al-Katan; Sylvia Pasternak; Giulio Bonavolontà; Diego Strianese; Peerooz Saeed; Kenneth A Feldman; Sumalee Vangveeravong; Jocelyne S Lapointe; Valerie A White
Journal:  Arch Ophthalmol       Date:  2009-08

8.  Clinicopathologic review of 142 cases of lacrimal gland lesions.

Authors:  C L Shields; J A Shields; R C Eagle; J P Rathmell
Journal:  Ophthalmology       Date:  1989-04       Impact factor: 12.079

9.  Magnetic resonance imaging of unilateral lacrimal gland lesions.

Authors:  Kaan Gündüz; Carol L Shields; Ilhan Günalp; Jerry A Shields
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-10-25       Impact factor: 3.117

10.  Primary adenocarcinoma of the lacrimal gland. A retrospective study.

Authors:  R S Heaps; N R Miller; D M Albert; W R Green; S Vitale
Journal:  Ophthalmology       Date:  1993-12       Impact factor: 12.079

View more
  9 in total

1.  Expression of survivin in adenoid cystic carcinoma of the lacrimal gland and the effect of intervention with arsenic trioxide in vitro.

Authors:  Yingzhe Pan; Yiqiao Xing; Hui Wang
Journal:  Exp Ther Med       Date:  2015-04-30       Impact factor: 2.447

Review 2.  Lacrimal gland adenoid cystic carcinoma with high-grade transformation to myoepithelial carcinoma: report of a case and review of literature.

Authors:  Prokopios P Argyris; Stefan E Pambuccian; Zuzan Cayci; Charanjeet Singh; Konstantinos I Tosios; Ioannis G Koutlas
Journal:  Head Neck Pathol       Date:  2012-07-25

3.  Clinico-radiological features of primary lacrimal gland pleomorphic adenoma: an analysis of 37 cases.

Authors:  Akihide Watanabe; Nicholas H Andrew; Kosuke Ueda; Shigeru Kinoshita; Nobutada Katori; Michael Reid; Adnan Pirbhai; Dinesh Selva
Journal:  Jpn J Ophthalmol       Date:  2016-05-16       Impact factor: 2.447

4.  miR-24-3p Suppresses Malignant Behavior of Lacrimal Adenoid Cystic Carcinoma by Targeting PRKCH to Regulate p53/p21 Pathway.

Authors:  Ming-Xue Zhang; Jie Zhang; Hong Zhang; Hua Tang
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

5.  Low-Grade Mucoepidermoid Carcinoma of the Lacrimal Gland in a Teenaged Patient.

Authors:  Ozgun Melike Gedar Totuk; Mustafa Kemal Demir; Ozlem Yapicier; Mert Mestanoglu
Journal:  Case Rep Ophthalmol Med       Date:  2017-11-28

6.  Outcomes in patients with lacrimal gland carcinoma treated with definitive radiotherapy or eye-sparing surgery followed by adjuvant radiotherapy.

Authors:  Yun-Hsuan Lin; Shih-Ming Huang; Wing-Keen Yap; Ju-Wen Yang; Ling Yeung; Din-Li Tsan; Joseph Tung-Chieh Chang; Lung-Chien Chen
Journal:  Radiat Oncol       Date:  2020-06-22       Impact factor: 3.481

7.  Carbon-ion radiotherapy in accelerated hypofractionated active raster-scanning technique for malignant lacrimal gland tumors: feasibility and safety.

Authors:  Sati Akbaba; Kristin Lang; Thomas Held; Klaus Herfarth; Juliane Rieber; Peter Plinkert; Gerd U Auffarth; Stefan Rieken; Juergen Debus; Sebastian Adeberg
Journal:  Cancer Manag Res       Date:  2019-02-01       Impact factor: 3.989

8.  Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma.

Authors:  Jie Yang; Chuandi Zhou; Yefei Wang; Xianqun Fan; Renbing Jia
Journal:  BMC Ophthalmol       Date:  2019-06-08       Impact factor: 2.209

9.  Epithelial Lacrimal Gland Tumours in Nigeria: Clinicopathological Features and Treatment.

Authors:  Oluyemi Fasina; Adewunmi Oluseye Adeoye; Olanipekun Olalekan Aremu
Journal:  J West Afr Coll Surg       Date:  2022-03-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.